🔎 Trials Near Me

Gara Jalqabaatti › Obesity › North Carolina › Charlotte

Qorannoo klinikaalii Obesity Charlotte, NC keessatti

Qorannoo 16 Obesity f Charlotte fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Namoota walitti qabaa jiraSadarkaa 3
  • Novant Health Heart and Vascular Institute, Charlotte
  • Monroe Biomedical Research, Monroe · Miili 24 fagaatti
Umuriin 45 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07037433

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Namoota walitti qabaa jiraSadarkaa 2
  • Monroe Biomedical Research /ID# 282009, Monroe · Miili 24 fagaatti
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07752979

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Namoota walitti qabaa jiraSadarkaa 2
  • Monroe Biomedical Research, Monroe · Miili 24 fagaatti
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07589608

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • Monroe Biomedical Research, Monroe · Miili 24 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07321886

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Monroe · Miili 24 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • AURORA-2 Clinical Site, Charlotte
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Namoota walitti qabaa jiraSadarkaa 3
  • AURORA-1 Clinical Site, Charlotte
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07743463

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Namoota walitti qabaa jiraSadarkaa 3Hojjettoota fayyaa simatamoo
  • ACCOMPLISH-2 Research Site, Charlotte
Umuriin 18 hanga 79 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Namoota walitti qabaa jiraSadarkaa 2
  • Monroe Biomedical Research, Monroe · Miili 24 fagaatti
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT06143956

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Namoota walitti qabaa jiraSadarkaa 4
  • Onsite Clinical Solutions - Huntersville, Huntersville · Miili 13 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT06857942

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • Kailera Clinical Site, Monroe · Miili 24 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07284901

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Namoota walitti qabaa jiraSadarkaa 2
  • Levine Children's Hospital, Charlotte
Umuriin 7 hanga 25 · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT05082519

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Namoota walitti qabaa jiraSadarkaa 3
  • Piedmont Research Partners, LLC, Fort Mill · Miili 16 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Namoota walitti qabaa jiraSadarkaa 3
  • ACCOMPLISH-1 Research Site, Charlotte
Umuriin 18 hanga 79 · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT07654361

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Namoota walitti qabaa jiraSadarkaa 1
  • Monroe Biomedical Research, LLC, Monroe · Miili 24 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Wax-2026 · NCT07607587

A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.

Namoota walitti qabaa jiraSadarkaa 2
  • Monroe Biomedical Research, Monroe · Miili 24 fagaatti
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT07570758

Qorannoo Obesity magaalota biroo keessatti

Qorannoo biroo Charlotte keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.